Abstract. A decreased growth hormone response to various secretagogues has been described in Turner's syndrome, but the mechanisms responsible for this decrease are unknown. Seventeen prepubertal girls with Turner's syndrome (age 6.4 to 15.7 years; height \m=-\0.2to \m=-\5.4sd, bone age \m=-\3.7 to \m=-\0.3sd; weight 93 to 169% of ideal body weight) underwent a stimulation test with GHRH (0.5 \g=m\g/kg). Plasma GH and prolactin were measured by radioimmunoassay from \m=-\30to +120 min and insulin-like growth factor-I at time 0. These values were compared with those observed in lean children with constitutional short stature. Peak plasma GH after GHRH was 17.0\m=+-\3.6 \g=m\g/l(mean\m=+-\sem),significantly lower (p<0.001) than in the short lean children (39.2\m=+-\5.1\g=m\g/l. In Turner's syndrome patients, the peak GH value was negatively correlated with the percentage of ideal body weight (r=\m=-\0.58, p<0.02) and of body fat (r=\m=-\0.59,p<0.02). Plasma prolactin levels in Turner's syndrome did not rise after GHRH and showed a normal circadian variation, from 8.0\m=+-\1.0 \g=m\g/l at 08.30 h to 5.0\m=+-\0.7 \g=m\g/l at 11.00 h (mean \m=+-\sem). Mean (\m=+-\sem) baseline plasma insulin-like growth factor-I concentrations was 0.88\m=+-\0.14kU/l, higher than in the short lean children (0.49\m=+-\0.08kU/l, p<0.05). We conclude that the decreased GH response to GHRH of girls with Turner's syndrome is related, at least in part, to their excess body weight and fat and is associated with higher IGF-I levels than in short lean children.
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Girls with Turner's syndrome have abnormal growth patterns and short final stature (1 Plasma GH and PRL levels were determined by RIA using kits purchased from Pharmacia (Sweden) and Serono (Switzerland), respectively. Plasma IGFT levels were measured by RIA after acid-ethanol extraction (to remove the interference of IGF binding proteins), as pre¬ viously described (7) . The sensitivity of the RIAs was 1 ng/1 for GH, 0.5 ng/1 for PRL, and 0.1 kU/1 for IGF-I. Mid-curve intra-and inter-assay coefficients of variation were 5 and 6%, 4 and 12%, and 10 and 15% for GH, PRL and IGF-I, respectively. Bone age was assessed by the method of Greulich & Pyle (14) . The (7) (8) (9) and obese adults (10, 11) . The mechanisms responsible for the decreased response to GHRH in human obesity are complex: in obese children, a slight increase in circulating IGF-I concentrations has been described and it has been suggested that increased IGF-I levels may reduce GH secretion either directly at the level of the pituitary or indi¬ rectly through increased somatostatin release from the hypothalamus (7) (8) (9) . In obese adults, however, circulating IGF-I levels are not elevated, suggesting that other factors play a role in the decreased GH responsiveness to GHRH associated with obesity: free fatty acids, glucose and insulin have been proposed as peripheral metabolic signals that may lead to the decreased GH response to GHRH observed in obese adults (10) .
The normal basal PRL levels and the lack of an acute increase in PRL after GHRH in Turner's syn¬ drome suggest that the decreased GH responsive¬ ness to GHRH of these patients is not due to a primary GHRH deficiency: we (13) and others (16) have shown that such an increase in PRL after GHRH is a hallmark of children with hypothalamic GHRH deficiency, although its precise mechanism remains unknown (17) .
Plasma IGF-I concentrations in prepubertal girls with Turner's syndrome have previously been found to be similar to those of prepubertal girls of normal height (18, 19) . In the present study, we compared the values of girls with Turner's syn¬ drome with those of a group of prepubertal chil- (20, 21) ; these higher IGF-I levels in Turner's syn¬ drome may be induced by the hyperinsulinemia which has been reported in this condition (22) and/or may be a reflection of the putative end-or¬ gan resistance to IGF-I (2). At later ages, IGF-I levels in Turner's syndrome become lower than normal, probably as a consequence of estrogen de¬ ficiency (18, 19) . The degree of obesity of girls with Turner's syn¬ drome is variable. In the present sample, mean body weight was 121.9% of ideal body weight, whereas in the obese children we previously re¬ ported (7) it was 147% of ideal body weight. This may explain, at least in part, the fact that the GH responsiveness to GHRH is less blunted in the former than in the latter (peak GH 49 and 32% of that observed in the short lean children, respec¬ tively); it may also account for the fact that plasma IGF-I levels, even though they were higher in Turner's syndrome than in short lean children, were not as high as those observed in children with idiopathic obesity (7) .
The importance of obesity in the regulation of GH secretion and action in Turner's syndrome is also suggested by the fact that GH treatment of short, overweight patients with Turner's syndrome results in supraphysiological plasma IGF-I levels (20) , a phenomenon not seen in short lean children (21) and consistent with the greater sensitivity of obese individuals to the IGF-I stimulating effect of exogenous GH (23) .
It has been suggested that the abnormalities of GH secretion observed in Turner's syndrome were related to estrogen deficiency. Schober et al. (6) have, however, shown that estrogen treatment does not modify the GH response to GHRH in Turner's syndrome, suggesting that estrogens act on GH se¬ cretion through suprapituitary mechanisms; they also concluded that the abnormality of body weight and adiposity should be taken into account when GH values are evaluated in Turner's syndrome.
In summary, we found that girls with Turner's syndrome have decreased GH responses to GHRH and increased plasma IGF-I concentrations com¬ pared with short lean prepubertal children. The GH response to GHRH is inversely correlated with the degree of overweight and with the amount of body fat. In conclusion, among the many factors influencing GH secretion and action, obesity should be taken into account in studies of girls with Turner's syndrome.
